AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Spinal Cord Associative Plasticity Study

RecruitingEARLY Phase 1Ages 18 Years - 80 YearsAllColumbia University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Spinal cord associative plasticity (SCAP) is a combined cortical and spinal electrical stimulation technique developed to induce recovery of arm and hand function in spinal cord injury. The proposed study will advance understanding of SCAP, which is critical to its effective translation to human therapy. The purpose of the study is to: 1. Determine whether signaling through the spinal cord to the muscles can be strengthened by electrical stimulation. 2. Improve our understanding of the spinal cord and how it produces movement. 3. Determine whether spinal surgery to relieve pressure on the spinal cord can improve its function. Aim 1 is designed to advance mechanistic understanding of spinal cord associative plasticity (SCAP). Aim 2 will determine whether SCAP increases spinal cord excitability after the period of repetitive pairing. In rats, SCAP augments muscle activation for hours a

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
NON-INVASIVE Inclusion Criteria: (All participants) * Age between 18-80 years. * Must have stable prescription medication for 30 days prior to screening * Must be able to: abstain from alcohol, smoking and caffeine consumption on the day of each experiment; abstain from recreational drugs for the entirety of the study; commit to study requirements (i.e., 7 visits); provide informed consent. (Able-bodied participants) * No known central or peripheral neurological disease or injury. (SCI participants - including patients scheduled for intraoperative procedures) * Score of 1-4 (out of 5) on manual muscle testing of finger extension, finger flexion, or finger abduction in left or right hand. Exclusion criteria: (All participants) * Personal or extensive family history of seizures; * Ventilator dependence or patent tracheostomy site; * Use of medications that significantly lower seizure threshold, such as amphetamines, neuroleptics, dalfampridine, and bupropion; * History of stroke, brain tumor, brain abscess, or multiple sclerosis; * History of moderate or severe head trauma (loss of consciousness for greater than one hour or evidence of brain contusion or hemorrhage or depressed skull fracture on prior imaging); * History of implanted brain/spine/nerve stimulators, aneurysm clips, ferromagnetic metallic implants in the head (except for inside mouth); cochlear implants; cardiac pacemaker/defibrillator; intracardiac lines; currently increased intracranial pressure; or other contraindications to brain or spine stimulation; * Significant coronary artery or cardiac conduction disease; recent history of myocardial infarction and heart failure with an ejection fraction of less than 30% or with a New York Heart Association Functional Classification of Class III or IV; * Recent history (within past 6 months) of recurrent autonomic dysreflexia, defined as a syndrome of sudden rise in systolic pressure greater than 20 mm Hg or diastolic pressure greater than 10 mm Hg, without rise in heart rate, accompanied by symptoms such as headache, facial flushing, sweating, nasal congestion, and blurry vision (this will be closely monitored during all screening and testing procedures); * History of significant hearing problems; * History of bipolar disorder; * History of suicide attempt; * Active psychosis; * Recent history (\>1 year) of chemical substance dependency or significant psychosocial disturbance; * Heavy alcohol consumption (greater than equivalent of 5oz of liquor) within previous 48 hours; * Open skin lesions over the face, neck, shoulders, or arms; * Pregnancy; and * Unsuitable for study participation as determined by study physician. INTRA-OPERATIVE Inclusion Criteria: * Clinical indication for cervical spine surgery. Exclusion criteria: (For experiments involving cortical stimulation) * Epilepsy; * A history of skull surgery with metal implants; * Cochlear implants; * Patients with aneurysm stents in neck or brain blood vessels; * Evidence of skull shrapnel; (For experiments involving spinal cord stimulation) * Stimulation devices in the neck or chest (e.g., vagal nerve stimulation, cardiac patients with pacemakers)
๐Ÿ’Š

What it tests

  • Non-invasive pairing of cortical and spinal stimulation
  • Intraoperative pairing of cortical and spinal stimulation
  • Non-invasive repeated pairing of cortical and spinal stimulation (SCAP)
  • Intraoperative repeated pairing of cortical and spinal stimulation (SCAP)
  • Intraoperative repeated pairing of cortical and spinal stimulation (SCAP) at or below myelopathic region
๐Ÿ“

Where

3 sites
Bronx Veterans Medical Research Foundation, Inc
New York, United States
Columbia University Irving Medical Center
New York, United States
Weill Cornell Medicine
New York, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy